IRegent, Jim Mellon’s Hong Kong investment group, provides initial backing for a new genetic medicine fund.
John Major will be the firm's European chairman. Christopher Finn explains why, and looks at other developments inside the firm.
Epartners has given back its e-money. The firm has decided it cannot invest $520m of the $650m fund it raised for internet companies last July and will return it to investors including Morgan Stanley and Softbank.
The venture capitalist has announced a $950m fund aimed at biotech and IT, but not the internet. Institutionals on both sides of the Atlantic contributed to the fund.
Money from Merlin Bioscience, Citigroup, Verus and 3i; initial close from Vertex.
Former analyst Michael Wand brings ‘deep insight into the software landscape' to the group.
Investors in the Scottish fund include Bank of Scotland, Old Mutual, Northern Rock Plc and Fortis Bank SA/NV.
Craig McCallum and Brian Aiken have been taken on as part of Protégé's expansion programme.
Global Equity Partners and Go Equity also participated in the round.
The fund will focus on the Nordic region and Germany and will make investments in established industrial and services companies.
The size of the investment has not been disclosed but it's reported that the deal values Comstock at "a substantial premium" over its first round valuation.
The two companies see this as a good time to explore investment opportunities in Latin America.
This fourth round brings the total raised by the company to E389m.
The two new appointees will be based in Carlyle’s London office.
Geocapital, Apax, Advent, VCF Partners and Chase Episode 1 sign the cheques.